PROTEA BIOSCIENCES GROUP, INC.

Profile

Company Names

PROTEA BIOSCIENCES GROUP, INC.

Addresses

1311 PINEVIEW DRIVE, SUITE 501, MORGANTOWN, WV 26505

1311 PINEVIEW DRIVE, MORGANTOWN, WV 26505

1311 PINEVIEW DRIVE, SUITE 501, MORGANTOWN, WV 26505

955 HARTMAN RUN ROAD, MORGANTOWN, WV 26507

Phone Numbers

304-292-2226
304 292-2226

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$13,391,208.00

Number of Funding Rounds:

18
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
18
2016-11-03 
$631,680.00 
$5,000,000.00 
$4,368,320.00 
Equity 
17
2016-05-20 
$691,000.00 
$2,500,000.00 
$1,809,000.00 
Debt 
16
2015-08-27 
$452,500.00 
$4,000,000.00 
$3,547,500.00 
Equity 
15
2015-05-22 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
14
2014-10-31 
$4,426,528.00 
$12,000,000.00 
$7,573,472.00 
Equity 
13
2014-04-02 
$600,000.00 
$900,000.00 
$300,000.00 
Debt 
12
2013-10-25 
$275,000.00 
$750,000.00 
$475,000.00 
Debt 
11
2013-09-25 
$700,000.00 
$8,000,000.00 
$7,300,000.00 
Equity 
10
2013-08-27 
$345,000.00 
$1,000,000.00 
$655,000.00 
Debt 
9
2013-07-15 
$439,500.00 
$1,000,000.00 
$560,500.00 
Debt 
8
2013-04-23 
$680,000.00 
$1,500,000.00 
$820,000.00 
Equity 
7
2012-12-16 
$0.00 
$3,000,000.00 
$3,000,000.00 
Equity 
6
2012-11-30 
$915,000.00 
$915,000.00 
$0.00 
Debt 
5
2012-08-22 
$450,000.00 
$6,000,000.00 
$5,550,000.00 
Equity 
4
2012-05-04 
$305,000.00 
$6,000,000.00 
$5,695,000.00 
Equity 
3
2011-12-27 
$280,000.00 
$10,000,000.00 
$9,720,000.00 
Equity 
2
2011-09-02 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2010-11-10 
$200,000.00 
$10,000,000.00 
$9,800,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVE 
 
ANTOLINE 
DIRECTOR
PROTEA BIOSCIENCES INC   |  PROTEA BIOSCIENCES GROUP, INC.
JOSIAH 
 
AUSTIN 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.
JOSIAH 
T. 
AUSTIN 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.   |  GOODRICH PETROLEUM CORP
ALESSANDRO 
 
BALDI 
EXECUTIVE OFFICER
PROTEA BIOSCIENCES GROUP, INC.
TOM 
 
CLARK 
DIRECTOR
COLLABNET INC   |  PROTEA BIOSCIENCES GROUP, INC.   |  SOCIAL DENTAL, INC.   |  GO BANYAN, INC.   |  MAGIC TOPCO, L.P.
DANIEL 
 
FLYNN 
DIRECTOR
PROTEA BIOSCIENCES INC   |  PROTEA BIOSCIENCES GROUP, INC.   |  CUIVRE RIVER BANCSHARES, INC.   |  FERNWEH DABICO HOLDINGS LLC   |  FERNWEH ENGAGED INVESTOR OPERATOR FUND II LP   |  FERNWEH ENGAGED INVESTOR OPERATOR FUND II-A LP
PATRICK 
 
GALLAGHER 
DIRECTOR
YOUMAIL INC   |  YOUMAIL, INC.   |  CRUNCH FUND I, L.P.   |  BRANDING BRAND, INC.   |  BIOSIG TECHNOLOGIES, INC.   |  PROTEA BIOSCIENCES GROUP, INC.   |  KUESKI, INC.   |  ALGORITHM SCIENCES, INC.   |  TUESDAY CAPITAL IV, L.P.   |  VOLTRON THERAPEUTICS, INC.   |  PURIFY FUELS, INC.   |  PD THERANOSTICS, INC.   |  AERWAVE MEDICAL, INC.   |  OVATION.IO, INC.   |  ALTO EXPERIENCE INC.   |  ADAPTIN BIO, INC.
DAVID 
 
HALVERSON 
EXECUTIVE OFFICER
PROTEA BIOSCIENCES GROUP, INC.
LEONARD 
 
HARRIS 
DIRECTOR
PEDIMENT GOLD CORP.   |  GOLDEN ARROW RESOURCES CORP   |  ENDEAVOUR SILVER CORP   |  SULLIDEN EXPLORATION INC   |  INDICO RESOURCES LTD.   |  CANARC RESOURCE CORP   |  AZTEC METALS CORP   |  SULLIDEN GOLD CORP LTD.   |  GOLDEN ALLIANCE RESOURCES CORP.   |  PROTEA BIOSCIENCES GROUP, INC.   |  CARDERO RESOURCE CORP.   |  SOLITARIO EXPLORATION + ROYALTY CORP.   |  WEALTH MINERALS LTD.
STEVE 
 
HARRIS 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.   |  BE AFRAID MEDIA, INC.
STANLEY 
 
HOSTLER 
EXECUTIVE OFFICER, DIRECTOR
PROTEA BIOSCIENCES INC   |  PROTEA BIOSCIENCES GROUP, INC.
EDWARD 
 
HUGHES 
EXECUTIVE OFFICER
PROTEA BIOSCIENCES GROUP, INC.
RODERICK 
 
JACKSON 
DIRECTOR
PROTEA BIOSCIENCES INC   |  PROTEA BIOSCIENCES GROUP, INC.   |  SANCILIO + COMPANY, INC.
GREG 
 
KILBY 
EXECUTIVE OFFICER
PROTEA BIOSCIENCES GROUP, INC.
GREGORY 
 
KILBY 
EXECUTIVE OFFICER
PROTEA BIOSCIENCES GROUP, INC.
STEVE 
 
O-LOUGHLIN 
EXECUTIVE OFFICER
PROTEA BIOSCIENCES GROUP, INC.   |  CNS PHARMACEUTICALS, INC.
MATTHEW 
 
POWELL 
EXECUTIVE OFFICER
FAT SPANIEL TECHNOLOGIES, INC.   |  PROTEA BIOSCIENCES GROUP, INC.
MILAN 
 
PUSKAR 
DIRECTOR
PROTEA BIOSCIENCES INC   |  PROTEA BIOSCIENCES GROUP, INC.
ED 
 
ROBERSON 
DIRECTOR
PROTEA BIOSCIENCES INC   |  PROTEA BIOSCIENCES GROUP, INC.
ED 
 
ROBERTSON 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.
SCOTT 
 
SEGAL 
DIRECTOR
PROTEA BIOSCIENCES INC   |  PROTEA BIOSCIENCES GROUP, INC.   |  ANSWER PAGE INC   |  PROJECT TRAVEL, LLC   |  EXUMA BIOTECH CORP.
MAGED 
 
SHENOUDA 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.   |  AZURRX BIOPHARMA, INC.   |  RELMADA THERAPEUTICS, INC.
JOHAN (THIJS) 
M. 
SPOOR 
DIRECTOR
FLUOROPHARMA MEDICAL, INC.   |  PROTEA BIOSCIENCES GROUP, INC.   |  METASTAT, INC.
STEPHEN 
 
TURNER 
EXECUTIVE OFFICER, DIRECTOR
PROTEA BIOSCIENCES INC   |  ACCEPT SOFTWARE CORP   |  PROTEA BIOSCIENCES GROUP, INC.   |  PRIORIA ROBOTICS HOLDINGS, INC.   |  ENVIRAL TECH, INC.   |  PANGIO BIOSYSTEMS, LLC
STEPHEN 
A. 
TURNER 
EXECUTIVE OFFICER, DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.
ANDREW 
 
ZULAUF 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.
C. ANDREW 
 
ZULAUF 
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.   |  BILLOW GLOBAL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-11-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2016-11-03 
2016-06-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Debt 
2016-05-20 
2015-09-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2015-08-27 
2015-06-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Debt 
2015-05-22 
2014-11-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-10-31 
2014-04-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-04-02 
2014-04-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-04-02 
2013-10-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-10-25 
2013-10-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-09-25 
2013-09-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-08-27 
2013-07-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-07-15 
2013-04-25
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-04-23 
2012-12-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-12-16 
2012-12-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2012-11-30 
2012-09-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
2012-05-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-05-04 
2012-01-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-12-27 
2011-11-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2010-11-10 
2011-09-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-09-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
BROOKLINE GROUP, LLC
153587
BROOKLINE GROUP, LLC
153587
WESTPARK CAPITAL, INC.
39914
WESTPARK CAPITAL, INC.
39914
BROOKLINE SECURITIES LLC
153587
BROOKLINE SECURITIES LLC
153587
NONE
NONE
SUMMER STREET RESEARCH PARTNERS
127142